depo medroxyprogesterone acetate
Showing 1 - 25 of 1,326
Endometriosis Ovary Trial in Semarang (Dienogest, Depo Medroxyprogesterone acetate, Leuprolide (as Leuprolide Acetate))
Recruiting
- Endometriosis Ovary
- Dienogest
- +3 more
-
Semarang, Central Java, IndonesiaKariadi Hospital
Nov 22, 2023
Human Immunodeficiency Virus, Contraception, ART Trial in Gaborone (Dolutegravir, Levonorgestrel implant, Depo
Recruiting
- Human Immunodeficiency Virus
- +2 more
- Dolutegravir
- +2 more
-
Gaborone, BotswanaPrincess Marina Hospital
Mar 1, 2022
Drug-drug Interactions Between Hormonal Contraceptives and
Recruiting
- HIV Infections
- +2 more
- Etonogestrel (ETG) implant
- +3 more
-
Johannesburg, South AfricaWits Reproductive Health and HIV Institute, Research Centre Clin
Feb 28, 2022
HIV, Contraception, Drug-drug Interaction Trial in Eldoret (Cabotegravir/ Rilpivirine, Etonogestrel (ETG) implant, Intramuscular
Recruiting
- HIV Infections
- +2 more
- Cabotegravir/ Rilpivirine
- +4 more
-
Eldoret, KenyaAcademic Model Providing Access to Healthcare (AMPATH) Moi Teach
Mar 30, 2022
Abnormal Uterine Bleeding, Tranexamic Acid, Estrogen Trial in Bangkok, Phaya Thai (Tranexamic acid 250 mg oral tablet, Progynova
Not yet recruiting
- Abnormal Uterine Bleeding
- +3 more
- Tranexamic acid 250 mg oral tablet
- Progynova 1 mg oral tablet
-
Bangkok, Ratchathewi, Thailand
- +1 more
Sep 27, 2023
Metrorrhagia Trial in New York (Femring®, DepoProvera ®)
Completed
- Metrorrhagia
- Femring®
- DepoProvera ®
-
New York, New YorkTitle X Family Planning Clinic
Dec 7, 2021
Hormonal Contraceptive Methods on Immunologic Changes in Female
Recruiting
- Hormonal Contraception
- Depot medroxyprogesterone acetate (DMPA)
- +2 more
-
Atlanta, Georgia
- +2 more
Aug 15, 2022
Quick Start of Highly Effective Contraception
Active, not recruiting
- IUD
- +4 more
- Copper T-380 IUD
- +3 more
-
West Valley City, UtahPlanned Parenthood Association of Utah
May 4, 2022
Contraception Trial in Santo Domingo (TV-46046, Depo-subQ 104, TV-46046 Placebo)
Completed
- Contraception
- TV-46046
- +2 more
-
Santo Domingo, Dominican RepublicTeva Investigational Site 1
Nov 18, 2021
Gender Dysphoria, Adolescent Trial in Denver (Depo-subQ Provera Injectable Product)
Recruiting
- Gender Dysphoria, Adolescent
- Depo-subQ Provera Injectable Product
-
Denver, ColoradoComprehensive Women's Health Center
Feb 13, 2023
Photorefractive Keratectomy Trial in Isfahan (prepared drop of medroxy progestrone acetat 1%)
Completed
- Photorefractive Keratectomy
- prepared drop of medroxy progestrone acetat 1%
-
Isfahan, Iran, Islamic Republic of
- +1 more
Jul 26, 2023
Atypical Endometrial Hyperplasia, Endometrial Carcinoma Stage I Trial in Peking (Medroxyprogesterone acetate + Atorvastatin)
Recruiting
- Atypical Endometrial Hyperplasia
- Endometrial Carcinoma Stage I
- Medroxyprogesterone acetate + Atorvastatin
-
Peking, Beijing, ChinaWang Jianliu
Dec 29, 2022
Contraception Trial in Cypress, San Antonio (TV-46046, DeposubQ Provera)
Active, not recruiting
- Contraception
- TV-46046
- DeposubQ Provera
-
Cypress, California
- +2 more
Nov 18, 2022
Infertility Trial in Istanbul (Gonadotropin releasing hormone antagonist (Cetrotide), Medroxyprogesterone Acetate (Tarlusal),
Not yet recruiting
- Infertility
- Gonadotropin releasing hormone antagonist (Cetrotide)
- +2 more
-
Istanbul, TurkeyBezmialem Vakif University
Mar 13, 2023
Contraception Trial (Depot-Medroxyprogestereone Acetate)
Not yet recruiting
- Contraception
- Depot-Medroxyprogestereone Acetate
- (no location specified)
Aug 15, 2022
Fertility Sparing Trial in Beijing (Medroxyprogesterone Acetate 500 MG Oral Tablet, Levonorgestrel-Releasing Intrauterine
Recruiting
- Fertility Sparing
- Medroxyprogesterone Acetate 500 MG Oral Tablet
- Levonorgestrel-Releasing Intrauterine System
-
Beijing, Beijing, ChinaBei Jing Chao-Yang Hospital
Oct 3, 2022
Knee Osteoarthritis Trial (ACP Max™, Depo-Medrol®)
Not yet recruiting
- Knee Osteoarthritis
- ACP Max™
- Depo-Medrol®
- (no location specified)
Mar 1, 2023
Endometrial Tumor Malignant Stage I Trial in Shanghai (Megestrol Acetate 160 MG Oral Tablet, Medroxyprogesterone Acetate 500 MG,
Recruiting
- Endometrial Neoplasm Malignant Stage I
- Megestrol Acetate 160 MG Oral Tablet
- +3 more
-
Shanghai, Shanghai, China, ChinaObstetrics and Gynecology Hospital, Fudan University
Mar 25, 2022
Arteriovenous Malformations Trial (MedroxyPROGESTERone Injection [Depo-Provera], Other)
Not yet recruiting
- Arteriovenous Malformations
- MedroxyPROGESTERone Injection [Depo-Provera]
- Other
- (no location specified)
Aug 4, 2022
Menorrhagia Trial in Sherbrooke (MPA, )
Terminated
- Menorrhagia
- MPA
- placebo
-
Sherbrooke, Quebec, CanadaCentre Hospitalier Universitaire de Sherbrooke
May 16, 2022
HIV, Contraception Trial in Atlanta (Depot medroxyprogesterone acetate (DMPA), Etonogestrel implant (Eng-Implant),
Completed
- HIV
- Contraception
- Depot medroxyprogesterone acetate (DMPA)
- +3 more
-
Atlanta, Georgia
- +3 more
Oct 23, 2020
Infertility Trial in Valencia (Provera 10 mg., Ganirelix (GnRH antagonist))
Completed
- Infertility
- Provera 10 mg.
- Ganirelix (GnRH antagonist)
-
Valencia, SpainIVI Valencia
Aug 24, 2021
Uterine Bleeding Trial in Assiut (Tranexamic acid, Medroxyprogesterone Acetate 150 MG/ML)
Recruiting
- Uterine Bleeding
- Tranexamic acid
- Medroxyprogesterone Acetate 150 MG/ML
-
Assiut, EgyptWomen Health Hospital - Assiut university
Aug 27, 2021
Healthy Trial in Brussels (Sayana Press)
Recruiting
- Healthy
- Sayana Press
-
Brussels, Bruxelles-capitale, Région DE, BelgiumBrussels Clinical Research Unit
May 23, 2022